(Q46701862)

24 December 2017

title

Obesity, hormone therapy, estrogen metabolism and risk of postmenopausal breast cancer (English)

1 reference

24 December 2017

0 references

1

Francesmary Modugno

1 reference

24 December 2017

9

Marcia L Stefanick

1 reference

24 December 2017

Lewis Kuller

4

object named as

Lewis Kuller

1 reference

24 December 2017

Rowan T Chlebowski

7

object named as

Rowan T Chlebowski

1 reference

24 December 2017

author name string

Kevin E Kip

2

1 reference

24 December 2017

Barbara Cochrane

3

1 reference

24 December 2017

Thomas L Klug

5

1 reference

24 December 2017

Thomas E Rohan

6

1 reference

24 December 2017

Norman Lasser

8

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

24 December 2017

International Journal of Cancer

published in

1 reference

24 December 2017

volume

118

1 reference

24 December 2017

issue

5

1 reference

24 December 2017

page(s)

1292-1301

1 reference

24 December 2017

Breast cancer and hormone-replacement therapy in the Million Women Study

cites work

1 reference

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

21 January 2018

1 reference

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial

21 January 2018

1 reference

Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin

21 January 2018

1 reference

Relationship between long durations and different regimens of hormone therapy and risk of breast cancer

21 January 2018

1 reference

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

The impact of dose and route of estrogen administration on the somatotropic axis in normal women

21 January 2018

1 reference

Markedly elevated levels of estrone sulfate after long-term oral, but not transdermal, administration of estradiol in postmenopausal women

21 January 2018

1 reference

Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women.

21 January 2018

1 reference

Endogenous estrogen and postmenopausal breast cancer: a quantitative review

21 January 2018

1 reference

Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States).

21 January 2018

1 reference

Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk

21 January 2018

1 reference

Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women

21 January 2018

1 reference

Associations between energy balance and body mass index and risk of breast carcinoma in women from diverse racial and ethnic backgrounds in the U.S.

21 January 2018

1 reference

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk

21 January 2018

1 reference

Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies

21 January 2018

1 reference

Functional role of estrogen metabolism in target cells: review and perspectives

21 January 2018

1 reference

16 alpha-hydroxylation of estradiol: a possible risk marker for breast cancer

21 January 2018

1 reference

Estradiol 16 alpha-hydroxylation in the mouse correlates with mammary tumor incidence and presence of murine mammary tumor virus: a possible model for the hormonal etiology of breast cancer in humans

21 January 2018

1 reference

Abnormal oxidative metabolism of estradiol in women with breast cancer.

21 January 2018

1 reference

Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women.

21 January 2018

1 reference

Upregulation of estradiol C16 alpha-hydroxylation in human breast tissue: a potential biomarker of breast cancer risk.

21 January 2018

1 reference

Do urinary oestrogen metabolites predict breast cancer? Guernsey III cohort follow-up

21 January 2018

1 reference

Estrogen metabolites and the risk of breast cancer in older women

21 January 2018

1 reference

Estrogens and breast cancer

21 January 2018

1 reference

Opposite effects of estrogen and catecholestrogen on hormone-sensitive breast cancer cell growth and differentiation.

21 January 2018

1 reference

The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth

21 January 2018

1 reference

Influence of body weight on estradiol metabolism in young women

21 January 2018

1 reference

The Women's Health Initiative recruitment methods and results

21 January 2018

1 reference

The women's health initiative observational study: baseline characteristics of participants and reliability of baseline measures

21 January 2018

1 reference

Predictors of the plasma ratio of 2-hydroxyestrone to 16alpha-hydroxyestrone among pre-menopausal, nulliparous women from four ethnic groups

21 January 2018

1 reference

Physical activity and cancer etiology: associations and mechanisms

21 January 2018

1 reference

Urinary estrogen metabolites and breast cancer: differential pattern of risk found with pre- versus post-treatment collection

21 January 2018

1 reference

Weight gain in women diagnosed with breast cancer

21 January 2018

1 reference

Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Study of Osteoporotic Fractures Research Group

21 January 2018

1 reference

Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65–79 years

21 January 2018

1 reference

Design of the Women’s Health Initiative Clinical Trial and Observational Study

21 January 2018

1 reference

Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women.

21 January 2018

1 reference

Implementation of the women's health initiative study design

21 January 2018

1 reference

Type of postmenopausal hormone use and risk of breast cancer: 12-year follow-up from the Nurses' Health Study

21 January 2018

1 reference

Role of Estradiol Metabolism and CYP1A1 Polymorphisms in Breast Cancer Risk

21 January 2018

1 reference

Monoclonal antibody-based enzyme immunoassay for simultaneous quantification of 2- and 16α-hydroxyesterone in urine

21 January 2018

1 reference

Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.21487

1 reference

24 December 2017

1 reference

24 December 2017